Drug
Interferon beta-1b (Betaferon®, BAY 86-5046)
Interferon beta-1b (Betaferon®, BAY 86-5046) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon
NCT01766063
completed
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon
NCT02247310
completed
BAY86-5046 (Betaseron), Non Interventional Studies
NCT02121444
Clinical Trials (3)
Showing 3 of 3 trials
NCT01766063
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon
NCT02247310
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon
NCT02121444
BAY86-5046 (Betaseron), Non Interventional Studies
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3